Grifols SA A (EUR)
GRF
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range30.84 | 31.46
52-Wk Range21.75 | 31.59
Last Close31.24
Mkt Cap (m)18,627.21
Dividend yield1.1%
ISINES0171996087
Volume562,675
Exchange VenueXMAD

Company Profile

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.

Key Information
Price/Earning39.05
Price/Book4.48
Price/Sales4.33
P/CF32.17
Rev Growth (3 year avg)4.47
EPS Growth (3 year avg)0.04
Operating Margin % 22.16
Net Margin %13.30
Return on Equity15.19
Debt/Equity1.49

Legal Documents

Prospectus
en 23/04/2015
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)2,7423,3553,9354,0504,3184,487
Operating Income (m)7368589709391,003994
Net Income (m)346470532545663597
Basic EPS0.510.690.780.800.970.87
Avg. Diluted Shares Outstanding (m)681685686684684685
Balance Sheet
EUR201320142015201620172018
Current Assets (m)2,1402,9133,0893,1232,9453,483
Non Current Assets (m)3,7015,5376,5127,0077,9758,994
Total Assets (m)5,8418,4509,60210,13010,92012,477
Current Liabilities (m)7151,0801,0531,0729781,257
Total Liabilities (m)------
Total Equity (m)2,1012,6583,2963,7213,6294,226
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)592979743553842737
Capital Expenditure (m)-173-287-567-293-323-308
Figures are quoted in EUR unless stated otherwise
0.00 (0.00%)
31.24
Last Price